These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2019 related items for PubMed ID: 25801458

  • 1. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E.
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.
    Miller E, Andrews NJ, Waight PA, Slack MP, George RC.
    Lancet Infect Dis; 2011 Oct; 11(10):760-8. PubMed ID: 21621466
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Andrews N, Kent A, Amin-Chowdhury Z, Sheppard C, Fry N, Ramsay M, Ladhani SN.
    Vaccine; 2019 Jul 26; 37(32):4491-4498. PubMed ID: 31272872
    [Abstract] [Full Text] [Related]

  • 8. Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study.
    Choi YH, Bertran M, Litt DJ, Ladhani SN, Miller E.
    Lancet Public Health; 2024 Sep 26; 9(9):e654-e663. PubMed ID: 39153492
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.
    Vaccine; 2014 Jul 23; 32(34):4349-55. PubMed ID: 24657717
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC, Zimmerman CM, Papadouka V, Konty KJ, Zucker JR, Nattanmai GV, Jose S, Rosen JB.
    JAMA Pediatr; 2015 Jul 23; 169(7):646-52. PubMed ID: 25938798
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM, Shibl AM, Elgouhary A, Elsobky M.
    Vaccine; 2018 Oct 15; 36(43):6442-6448. PubMed ID: 30194003
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pneumococcal disease in South Australia: vaccine success but no time for complacency.
    Johnson DR, D'Onise K, Holland RA, Raupach JC, Koehler AP.
    Vaccine; 2012 Mar 09; 30(12):2206-11. PubMed ID: 22273663
    [Abstract] [Full Text] [Related]

  • 20. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
    Ciruela P, Izquierdo C, Broner S, Muñoz-Almagro C, Hernández S, Ardanuy C, Pallarés R, Domínguez A, Jané M, Catalan Working Group on Invasive Pneumococcal Disease.
    Vaccine; 2018 Nov 29; 36(50):7744-7752. PubMed ID: 30473132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.